Frost Radar : Digital Biomarkers, 2023

Digital biomarkers play a crucial role in early disease detection and prevention; data-driven insights generated by wearable support early diagnosis, real-time monitoring of patient health, precise healthcare delivery, remote patient monitoring, and advanced R&D effort in the treatment of neurodegenerative conditions. While innovation focuses on the development of contactless devices, vocal digital biomarkers, the use of AI, pharmaceutical companies are collaborating with digital health start-ups to speed up clinical trials, develop new products faster, and improve patient engagement and outcomes.

The Frost Radar™ aligns with the essence of the healthcare digital revolution, and it provides a gateway to a future approach where health management is patient-centric, proactive, and precise, enabled by digital biomarkers. The research study offers intelligence so that industry stakeholders can be at the forefront of that revolution.